With measles outbreaks surging, chemotherapy leaves most pediatric cancer survivors without protective antibodies. Read more on new data.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.